Adherence to medication: A nation-wide study from the Children's Cancer Hospital, Egypt

Hanan El Malla1, Nathalie Ylitalo Helm, Ulrica Wilderäng

  • 1Hanan El Malla, Nathalie Ylitalo Helm, Ulrica Wilderäng, Gunnar Steineck, Division of Clinical Cancer Epidemiology, Department of Oncology, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden.

Insights

Non-adherence to cancer treatment is common in Egyptian children, primarily due to child resistance and insufficient medical information. Improving communication and addressing resistance are key to enhancing adherence to medical regimens.

Area of Science:

  • Pediatric Oncology
  • Health Behavior Research
  • Cross-cultural Healthcare Studies

Background:

  • Adherence to medical regimens is crucial for effective cancer treatment in children.
  • Understanding non-adherence predictors in diverse healthcare settings is essential for improving patient outcomes.

Purpose of the Study:

  • To investigate adherence to medical regimens among pediatric cancer patients in Egypt.
  • To identify key predictors of non-adherence to cancer treatment in this population.

Main Methods:

  • A study involving 304 parents of children with cancer at a Cairo hospital.
  • Utilized questionnaires translated into Egyptian Arabic, administered by interviewers due to high illiteracy rates.
  • Data collected via questionnaires and child medical records over a 7-month period.

Main Results:

  • High rates of non-adherence reported, with 68% of parents indicating their child did not follow medical recommendations.
  • Primary predictors for non-adherence identified as child resistance (90%) and inadequate information (81%).
  • Trust in healthcare professionals was lower in the non-adherent group.

Conclusions:

  • Non-adherence to medical regimens is prevalent among children with cancer in Egypt.
  • Child resistance and insufficient information are the main drivers of non-adherence.
  • Strategies to improve information delivery and manage child resistance are needed.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
414
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
982
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
417
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
450
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
252
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
562